Prescription Acne Medication Dangers Ignored by Health Officials
The prescription acne medication drug Diane-35 is currently on the Canadian and French health care market. Although 150 different safety reviews have been conducted by Health Canada, Canada’s health care agency, all the information gathered remains classified and unavailable to the public.
Dangerous Acne Drug Prescribed Improperly
Diane-35 is marketed and sold as a short term acne treatment. It is meant to be taken for 21 days consecutively, with a seven day break.
However, many doctors and physicians have prescribed the drug and its generic type as birth control, which are being taken indefinitely for long periods of time. This presents an elevated risk to pulmonary embolisms that are associated with the drug.
Nearly 500,000 prescriptions of the drug were written in the last year.
Deaths after Taking Diane-35
- The safety of Diane-35 is under scrutiny in light of thirteen women dying from the side effects of the drug and potentially the way the medication has been prescribed.
- According to the Toronto Star, Marit McKenzie , age 18, died last January from a fatal blood clot, after being prescribed and taking Diane-35 for the treatment of acne.
- It was after midnight when, unable to walk, the young women phoned her parents from her bedroom to alert them that she was having difficulty breathing and suffering from chest pains.
- Her parent rushed her to the hospital where she later had four cardiac arrests. Less than two days later the young woman was taken off life support and pronounced dead, the initial cause of death was a “saddle” pulmonary embolism.
- In March, another 15-year-old girl died of a pulmonary embolism whose cause has been cited as taking Diane-35.
- Both deaths were reported to Health Canada, but the entity has still held that the benefits outweigh the risks.
Health Officials Vote on Safety
Members of the European Medicines Agency have recently voted to keep the drug on the market, despite votes from many members of EU to do otherwise.
Diane-35 is currently sold in 116 countries, the United States is not one of them.
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or medical devices, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.
RECENT MEDICAL MALPRACTICE RESULT
$10.9 MillionExpenses: $175,000.00 | Attorneys Fees: $3,200,000.00 | Net to Client: $4,029,762.00 (Purchase of a Lifetime Annuity)
RECENT VEHICLE RECALL RESULT
$30.2 MillionExpenses: $39,576.15 | Attorneys Fees: $10,060,980.00 | Net to Client: $20,121,960.57